PRKN and pachyonychia congenita: Furthermore, current studies have shown that HACD2 promotes PC progression by binding to PRKN and dissociating PKM2 from PRKN (Figure 5), decreasing PKM2 ubiquitination and leading to tumorigenesis and that this phenomenon is inhibited by PRKN overexpression (Figure 6).